Sharon Tetlow - Net Worth and Insider Trading

Sharon Tetlow Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sharon Tetlow owns 4 companies in total, including Catalyst Biosciences Inc (CBIO) , Ocera Therapeutics Inc (OCRX) , and DICE Therapeutics Inc (DICE) among others .

Click here to see the complete history of Sharon Tetlow’s form 4 insider trades.

Insider Ownership Summary of Sharon Tetlow

Ticker	Comapny	Transaction Date	Type of Owner
CBIO	Catalyst Biosciences Inc	2020-01-15	director
OCRX	Ocera Therapeutics Inc	2014-07-11	Acting CFO & Treasurer
DICE	DICE Therapeutics Inc	2021-09-14	director
		2023-02-02	director

Sharon Tetlow Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sharon Tetlow Ownership Network

Ownership Network List of Sharon Tetlow

No Data

Ownership Network Relation of Sharon Tetlow

Sharon Tetlow Owned Company Details

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Sharon Tetlow is the director of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Ocera Therapeutics Inc do?

Who are the key executives at Ocera Therapeutics Inc?

Sharon Tetlow is the Acting CFO & Treasurer of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .

Ocera Therapeutics Inc (OCRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocera Therapeutics Inc Insider Transactions

No Available Data

What does DICE Therapeutics Inc do?

Who are the key executives at DICE Therapeutics Inc?

Sharon Tetlow is the director of DICE Therapeutics Inc. Other key executives at DICE Therapeutics Inc include 10 percent owner Northpond Ventures Gp, Llc , CSO John R. Jacobsen , and director & CEO Kevin Judice .

DICE Therapeutics Inc (DICE) Insider Trades Summary

Over the past 18 months, Sharon Tetlow made no insider transaction in DICE Therapeutics Inc (DICE). Other recent insider transactions involving DICE Therapeutics Inc (DICE) include a net sale of 37,509 shares made by John R. Jacobsen , a net purchase of 1,007,701 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 2,492,871 shares made by Northpond Ventures Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,656,925 shares of DICE Therapeutics Inc (DICE) were sold and 1,007,701 shares were bought by its insiders, resulting in a net sale of 1,649,224 shares.

DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.

DICE Therapeutics Inc Insider Transactions

No Available Data

What does Structure Therapeutics Inc do?

Who are the key executives at Structure Therapeutics Inc?

Sharon Tetlow is the director of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .

Structure Therapeutics Inc (GPCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Structure Therapeutics Inc Insider Transactions

No Available Data

Sharon Tetlow Mailing Address

Above is the net worth, insider trading, and ownership report for Sharon Tetlow. You might contact Sharon Tetlow via mailing address: C/o Catalyst Biosciences, Inc., 611 Gateway Blvd., Suite 710, South San Francisco Ca 94080.

Discussions on Sharon Tetlow

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.